Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The SURMOUNT-1 trial found that participants on tirzepatide 15mg achieved an average weight loss of 20.9% of body weight, while the STEP 1 trial found semaglutide 2.4mg produced an average of 14.9%
The phase 3 TRIUMPH trial results, announced more recently, showed even longer-term data
Fill out the form to the right and send it over Corporate Office 23475 Rock Haven Way #105 Sterling, VA 20166 Tel: (855) 792-5462 Fax: (855) 792-5463 Hours of Operation Monday thru Friday: 8:30am 6:00pm EST Saturday: 9:00am 1:00pm EST Sunday: Closed Interested in joining our awesome team
Ozempic FDA Alerts The FDA Alerts below may be specifically about Ozempic or relate to a group or class of drugs which include Ozempic
As of January 2026, 13 states cover tirzepatide and other GLP-1 medications for weight loss
